Washington University Becker Library Makes MetaCore Accessible Throughout the University
News Feb 11, 2009
GeneGo, Inc. has announced that Becker Medical Library at Washington University in St. Louis has licensed MetaCore. The Becker Medical Library Bioinformatics@Becker program is a university wide resource which provides bioinformatics support for researchers and students.
MetaCore is a data mining tool that provides users with easy access to up to date pertinent pathway information. Researchers can run simple searches as well as very specific Boolean queries and have answers in seconds or minutes rather than weeks and months using traditional methods.
MetaCore can also be used for pathway analysis of all kinds of experimental data from gene expression, micro RNA to assay data as well as biomarker studies.
"Becker Medical Library at Washington University in St. Louis is an important customer for GeneGo as we build up the number of libraries using GeneGo products," said Julie Bryant, GeneGo's VP of Business development. "Libraries are the heart of most academic centers and an excellent resource for PI's, researchers and students where systems biology comes together with all types of experimental data, biologists, chemists and pharmacologists and therapeutic focuses."
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.